Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs
Open Access
- 5 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 34 (2) , 678-683
Abstract
Background Upper gastrointestinal (GI) ulceration and bleeding in critically ill dogs can cause severe anemia and increase morbidity. Acid suppressants using proton pump inhibitors or histamine‐2 receptor blockers administered IV is commonly recommended. Hypothesis/Objectives To evaluate the efficacy of IV administered esomeprazole, pantoprazole, and famotidine constant rate infusion (CRI) on increasing the intragastric pH of dogs. We hypothesized that esomeprazole and famotidine CRI would provide superior acid suppression compared to pantoprazole and reach pH goals for the treatment of GI bleeding. Animals Nine healthy research Beagles. Methods Randomized, 3‐way crossover. Dogs received pantoprazole or esomeprazole at 1 mg/kg IV q12h and famotidine with a loading dose of 1 mg/kg followed by 8 mg/kg IV CRI daily for 3 consecutive days. The intragastric pH was recorded at baseline and for 72 hours of treatment. The mean pH and the mean percentage time (MPT) the intragastric pH was ≥3 or ≥4 were compared among and within treatment groups. Results Significant increases in mean pH (P < 0.0001), MPT ≥3 (P < 0.001), and MPT ≥4 (P = 0.0006) were noted over time with all 3 treatments. The time effect did not differ by treatment for mean pH, MPT ≥3, and MPT ≥4 (P = .29, .56, and .37, respectively); however, only esomeprazole and famotidine CRI achieved the goals established for the treatment of gastroduodenal ulceration in people. Conclusions and Clinical Importance Famotidine CRI and esomeprazole might be superior acid suppressants compared to standard doses of pantoprazole for the first 72 hours of treatment.Keywords
Funding Information
- The Companion Animal Fund (CAF.2018.04)
- The Companion Animal Fund (CAF.2018.04)
This publication has 19 references indexed in Scilit:
- Efficacy of Intravenous Administration of Combined Acid Suppressants in Healthy DogsJournal of Veterinary Internal Medicine, 2015
- Intermittent vs Continuous Proton Pump Inhibitor Therapy for High-Risk Bleeding UlcersJAMA Internal Medicine, 2014
- Challenges in the management of acute peptic ulcer bleedingThe Lancet, 2013
- Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits Hsiu-Chi Cheng, Bor-Shyang SheuWorld Journal of Gastrointestinal Endoscopy, 2011
- An update on the use of pantoprazole as a treatment for gastroesophageal reflux diseaseClinical and Experimental Gastroenterology, 2010
- Packed Red Blood Cell Transfusions in Dogs With Gastrointestinal Hemorrhage: 55 Cases (1999–2001)Journal of the American Animal Hospital Association, 2003
- Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretionAlimentary Pharmacology & Therapeutics, 2003
- Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?Gastroenterology, 1994
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux DiseaseDigestion, 1992
- Is there an optimal degree of acid suppression for healing of duodenal ulcers?Gastroenterology, 1990